Publication:
Unusual Bleeding Due to Riociguat Use in a Patient With Chronic Thromboembolic Pulmonary Hypertension

dc.contributor.authorsSonmez, Asli; Sunbul, Murat; Yildizeli, Bedrettin; Mutlu, Bulent
dc.date.accessioned2022-03-12T20:27:27Z
dc.date.accessioned2026-01-11T10:33:21Z
dc.date.available2022-03-12T20:27:27Z
dc.date.issued2016
dc.description.abstractRiociguat is a new drug prescribed to patients with pulmonary hypertension that reduces the pressure in pulmonary artery by vasodilation. This drug like many other drugs has several side effects, some of which can be serious such as bleeding. Riociguat causes vaginal bleeding by increasing endometrial thickness and blood flow to the endometrium, therefore, should be used with care especially for patients who have history of dysfunctional uterine bleeding. In this case report, we present a 27-year-old female patient with chronic thromboembolic pulmonary hypertension and dysfunctional uterine bleeding presented with severe vaginal bleeding under riociguat treatment.
dc.identifier.doi10.1097/MJT.0000000000000327
dc.identifier.eissn1536-3686
dc.identifier.issn1075-2765
dc.identifier.pubmed26270800
dc.identifier.urihttps://hdl.handle.net/11424/233690
dc.identifier.wosWOS:000384446400024
dc.language.isoeng
dc.publisherLIPPINCOTT WILLIAMS & WILKINS
dc.relation.ispartofAMERICAN JOURNAL OF THERAPEUTICS
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectriociguat
dc.subjectpulmonary hypertension
dc.subjectbleeding
dc.subjectanemia
dc.titleUnusual Bleeding Due to Riociguat Use in a Patient With Chronic Thromboembolic Pulmonary Hypertension
dc.typearticle
dspace.entity.typePublication
oaire.citation.endPageE1254
oaire.citation.issue5
oaire.citation.startPageE1253
oaire.citation.titleAMERICAN JOURNAL OF THERAPEUTICS
oaire.citation.volume23

Files